CFLED(SZ:300301)2022-04-29 16:00Financial Performance - The company's revenue for Q1 2022 was ¥212,704,197.94, a decrease of 22.00% compared to ¥272,686,932.62 in the same period last year[3] - The net profit attributable to shareholders was -¥35,059,498.69, representing a decline of 89.65% from -¥18,486,906.39 year-on-year[3] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥42,696,496.21, down 97.42% from -¥21,627,431.12 in the previous year[3] - The basic and diluted earnings per share were both -¥0.0444, a decline of 89.74% from -¥0.0234 in the same period last year[3] - The total comprehensive income attributable to the parent company for Q1 2022 was -35,059,498.69 CNY, compared to -18,486,906.39 CNY in Q1 2021, reflecting a significant decline[16] Cash Flow - The net cash flow from operating activities was -¥27,613,642.90, a decrease of 3.59% compared to -¥26,656,685.47 in the same period last year[3] - Cash inflow from operating activities totaled 190,131,028.39 CNY, down from 255,251,043.50 CNY in Q1 2021, indicating a decrease of approximately 25.5%[18] - The cash outflow from operating activities was 217,744,671.29 CNY, compared to 281,907,728.97 CNY in the previous year, showing a reduction of about 22.8%[19] - The net cash flow from investing activities was 4,351,739.29 CNY, an increase from 3,264,904.27 CNY in Q1 2021[19] - The net cash flow from financing activities was 128,972,703.86 CNY, a significant improvement from -41,122,074.69 CNY in the same quarter last year[19] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,746,337,203.95, an increase of 2.77% from ¥1,699,245,494.41 at the end of the previous year[3] - Total liabilities rose to CNY 994.29 million in Q1 2022, up from CNY 912.13 million, marking an increase of 9.0%[12] - The company's cash and cash equivalents decreased to CNY 1,011.18 million from CNY 941.61 million, an increase of 7.4%[12] - The company's inventory decreased to CNY 185.05 million from CNY 193.46 million, a reduction of approximately 4.3%[12] - The total equity attributable to shareholders decreased to CNY 751.24 million from CNY 786.30 million, a decline of 4.5%[13] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 42,689[7] - The equity attributable to shareholders decreased by 4.46% to ¥751,235,903.04 from ¥786,295,401.73 at the end of the previous year[3] Research and Development - Research and development expenses for Q1 2022 were CNY 20.22 million, up from CNY 17.86 million in the previous year, reflecting a growth of 13.5%[14] Non-Recurring Gains - The company reported non-recurring gains of ¥7,636,997.52, which included government subsidies and non-current asset disposal gains[5] - The company reported a credit impairment loss of CNY 5.78 million, compared to CNY 0.85 million in the same period last year, indicating a significant increase in credit risk[15]